Everus Construction Group, Inc.
Everus Construction Group, Inc. (ECG) Stock Competitors & Peer Comparison
See (ECG) competitors and their performances in Stock Market.
Peer Comparison Table: Engineering & Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ECG | $112.60 | -0.29% | 5.7B | 28.52 | $3.95 | N/A |
| PWR | $559.02 | -1.39% | 83.7B | 82.23 | $6.80 | +0.07% |
| FIX | $1,365.34 | -0.61% | 48.2B | 47.37 | $28.85 | +0.16% |
| FER | $63.21 | -1.77% | 45.6B | 44.83 | $1.41 | +1.59% |
| EME | $709.91 | -0.09% | 31.8B | 25.17 | $28.21 | +0.16% |
| MTZ | $290.00 | -2.34% | 22.9B | 57.10 | $5.08 | N/A |
| APG | $39.92 | -2.11% | 17.2B | -57.86 | -$0.69 | N/A |
| J | $128.06 | -1.11% | 15.1B | 33.81 | $3.79 | +1.03% |
| STRL | $398.12 | -1.60% | 12.2B | 42.44 | $9.38 | N/A |
| ACM | $91.06 | +1.40% | 11.8B | 20.14 | $4.52 | +1.20% |
Stock Comparison
ECG vs PWR Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, PWR has a market cap of 83.7B. Regarding current trading prices, ECG is priced at $112.60, while PWR trades at $559.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas PWR's P/E ratio is 82.23. In terms of profitability, ECG's ROE is +0.37%, compared to PWR's ROE of +0.13%. Regarding short-term risk, ECG is more volatile compared to PWR. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check PWR's competition here
ECG vs FIX Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, FIX has a market cap of 48.2B. Regarding current trading prices, ECG is priced at $112.60, while FIX trades at $1,365.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas FIX's P/E ratio is 47.37. In terms of profitability, ECG's ROE is +0.37%, compared to FIX's ROE of +0.49%. Regarding short-term risk, ECG is more volatile compared to FIX. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check FIX's competition here
ECG vs FER Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, FER has a market cap of 45.6B. Regarding current trading prices, ECG is priced at $112.60, while FER trades at $63.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas FER's P/E ratio is 44.83. In terms of profitability, ECG's ROE is +0.37%, compared to FER's ROE of +0.36%. Regarding short-term risk, ECG is more volatile compared to FER. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check FER's competition here
ECG vs EME Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, EME has a market cap of 31.8B. Regarding current trading prices, ECG is priced at $112.60, while EME trades at $709.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas EME's P/E ratio is 25.17. In terms of profitability, ECG's ROE is +0.37%, compared to EME's ROE of +0.39%. Regarding short-term risk, ECG is more volatile compared to EME. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check EME's competition here
ECG vs MTZ Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MTZ has a market cap of 22.9B. Regarding current trading prices, ECG is priced at $112.60, while MTZ trades at $290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MTZ's P/E ratio is 57.10. In terms of profitability, ECG's ROE is +0.37%, compared to MTZ's ROE of +0.13%. Regarding short-term risk, ECG is less volatile compared to MTZ. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check MTZ's competition here
ECG vs APG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, APG has a market cap of 17.2B. Regarding current trading prices, ECG is priced at $112.60, while APG trades at $39.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas APG's P/E ratio is -57.86. In terms of profitability, ECG's ROE is +0.37%, compared to APG's ROE of +0.09%. Regarding short-term risk, ECG is more volatile compared to APG. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check APG's competition here
ECG vs J Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, J has a market cap of 15.1B. Regarding current trading prices, ECG is priced at $112.60, while J trades at $128.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas J's P/E ratio is 33.81. In terms of profitability, ECG's ROE is +0.37%, compared to J's ROE of +0.12%. Regarding short-term risk, ECG is more volatile compared to J. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check J's competition here
ECG vs STRL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, STRL has a market cap of 12.2B. Regarding current trading prices, ECG is priced at $112.60, while STRL trades at $398.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas STRL's P/E ratio is 42.44. In terms of profitability, ECG's ROE is +0.37%, compared to STRL's ROE of +0.30%. Regarding short-term risk, ECG is less volatile compared to STRL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check STRL's competition here
ECG vs ACM Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ACM has a market cap of 11.8B. Regarding current trading prices, ECG is priced at $112.60, while ACM trades at $91.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ACM's P/E ratio is 20.14. In terms of profitability, ECG's ROE is +0.37%, compared to ACM's ROE of +0.20%. Regarding short-term risk, ECG is more volatile compared to ACM. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check ACM's competition here
ECG vs DY Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, DY has a market cap of 10.4B. Regarding current trading prices, ECG is priced at $112.60, while DY trades at $347.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas DY's P/E ratio is 36.26. In terms of profitability, ECG's ROE is +0.37%, compared to DY's ROE of +0.19%. Regarding short-term risk, ECG is more volatile compared to DY. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check DY's competition here
ECG vs BLD Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, BLD has a market cap of 10.3B. Regarding current trading prices, ECG is priced at $112.60, while BLD trades at $367.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas BLD's P/E ratio is 20.10. In terms of profitability, ECG's ROE is +0.37%, compared to BLD's ROE of +0.24%. Regarding short-term risk, ECG is more volatile compared to BLD. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check BLD's competition here
ECG vs STN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, STN has a market cap of 10.1B. Regarding current trading prices, ECG is priced at $112.60, while STN trades at $88.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas STN's P/E ratio is 28.56. In terms of profitability, ECG's ROE is +0.37%, compared to STN's ROE of +0.14%. Regarding short-term risk, ECG is more volatile compared to STN. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check STN's competition here
ECG vs IESC Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, IESC has a market cap of 8.8B. Regarding current trading prices, ECG is priced at $112.60, while IESC trades at $442.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas IESC's P/E ratio is 26.35. In terms of profitability, ECG's ROE is +0.37%, compared to IESC's ROE of +0.41%. Regarding short-term risk, ECG is more volatile compared to IESC. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check IESC's competition here
ECG vs TTEK Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, TTEK has a market cap of 8.4B. Regarding current trading prices, ECG is priced at $112.60, while TTEK trades at $32.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas TTEK's P/E ratio is 24.20. In terms of profitability, ECG's ROE is +0.37%, compared to TTEK's ROE of +0.20%. Regarding short-term risk, ECG is less volatile compared to TTEK. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check TTEK's competition here
ECG vs PRIM Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, PRIM has a market cap of 7.2B. Regarding current trading prices, ECG is priced at $112.60, while PRIM trades at $133.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas PRIM's P/E ratio is 26.59. In terms of profitability, ECG's ROE is +0.37%, compared to PRIM's ROE of +0.17%. Regarding short-term risk, ECG is less volatile compared to PRIM. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check PRIM's competition here
ECG vs ROAD Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ROAD has a market cap of 6.4B. Regarding current trading prices, ECG is priced at $112.60, while ROAD trades at $113.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ROAD's P/E ratio is 51.57. In terms of profitability, ECG's ROE is +0.37%, compared to ROAD's ROE of +0.14%. Regarding short-term risk, ECG is less volatile compared to ROAD. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check ROAD's competition here
ECG vs AGX Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, AGX has a market cap of 6.4B. Regarding current trading prices, ECG is priced at $112.60, while AGX trades at $458.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas AGX's P/E ratio is 53.87. In terms of profitability, ECG's ROE is +0.37%, compared to AGX's ROE of +0.31%. Regarding short-term risk, ECG is less volatile compared to AGX. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check AGX's competition here
ECG vs FLR Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, FLR has a market cap of 6.3B. Regarding current trading prices, ECG is priced at $112.60, while FLR trades at $43.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas FLR's P/E ratio is -138.81. In terms of profitability, ECG's ROE is +0.37%, compared to FLR's ROE of -0.01%. Regarding short-term risk, ECG is more volatile compared to FLR. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check FLR's competition here
ECG vs LGN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, LGN has a market cap of 5.4B. Regarding current trading prices, ECG is priced at $112.60, while LGN trades at $50.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas LGN's P/E ratio is -391.54. In terms of profitability, ECG's ROE is +0.37%, compared to LGN's ROE of -0.11%. Regarding short-term risk, ECG is more volatile compared to LGN. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check LGN's competition here
ECG vs GVA Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, GVA has a market cap of 5.3B. Regarding current trading prices, ECG is priced at $112.60, while GVA trades at $120.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas GVA's P/E ratio is 31.12. In terms of profitability, ECG's ROE is +0.37%, compared to GVA's ROE of +0.18%. Regarding short-term risk, ECG is more volatile compared to GVA. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check GVA's competition here
ECG vs KBR Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, KBR has a market cap of 4.7B. Regarding current trading prices, ECG is priced at $112.60, while KBR trades at $36.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas KBR's P/E ratio is 10.50. In terms of profitability, ECG's ROE is +0.37%, compared to KBR's ROE of +0.28%. Regarding short-term risk, ECG is more volatile compared to KBR. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check KBR's competition here
ECG vs MYRG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MYRG has a market cap of 4.1B. Regarding current trading prices, ECG is priced at $112.60, while MYRG trades at $261.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MYRG's P/E ratio is 34.68. In terms of profitability, ECG's ROE is +0.37%, compared to MYRG's ROE of +0.20%. Regarding short-term risk, ECG is more volatile compared to MYRG. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check MYRG's competition here
ECG vs TPC Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, TPC has a market cap of 3.6B. Regarding current trading prices, ECG is priced at $112.60, while TPC trades at $67.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas TPC's P/E ratio is 44.89. In terms of profitability, ECG's ROE is +0.37%, compared to TPC's ROE of +0.07%. Regarding short-term risk, ECG is more volatile compared to TPC. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check TPC's competition here
ECG vs NVEE Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, NVEE has a market cap of 1.5B. Regarding current trading prices, ECG is priced at $112.60, while NVEE trades at $22.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas NVEE's P/E ratio is 41.78. In terms of profitability, ECG's ROE is +0.37%, compared to NVEE's ROE of +0.04%. Regarding short-term risk, ECG is more volatile compared to NVEE. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check NVEE's competition here
ECG vs AMRC Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, AMRC has a market cap of 1.3B. Regarding current trading prices, ECG is priced at $112.60, while AMRC trades at $24.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas AMRC's P/E ratio is 29.78. In terms of profitability, ECG's ROE is +0.37%, compared to AMRC's ROE of +0.04%. Regarding short-term risk, ECG is less volatile compared to AMRC. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check AMRC's competition here
ECG vs WLDN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, WLDN has a market cap of 1.2B. Regarding current trading prices, ECG is priced at $112.60, while WLDN trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas WLDN's P/E ratio is 22.78. In terms of profitability, ECG's ROE is +0.37%, compared to WLDN's ROE of +0.19%. Regarding short-term risk, ECG is less volatile compared to WLDN. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check WLDN's competition here
ECG vs JUNE Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, JUNE has a market cap of 1.2B. Regarding current trading prices, ECG is priced at $112.60, while JUNE trades at $59.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas JUNE's P/E ratio is -112.26. In terms of profitability, ECG's ROE is +0.37%, compared to JUNE's ROE of -0.21%. Regarding short-term risk, ECG is more volatile compared to JUNE. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check JUNE's competition here
ECG vs GLDD Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, GLDD has a market cap of 1.1B. Regarding current trading prices, ECG is priced at $112.60, while GLDD trades at $16.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas GLDD's P/E ratio is 15.67. In terms of profitability, ECG's ROE is +0.37%, compared to GLDD's ROE of +0.15%. Regarding short-term risk, ECG is more volatile compared to GLDD. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check GLDD's competition here
ECG vs LMB Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, LMB has a market cap of 923M. Regarding current trading prices, ECG is priced at $112.60, while LMB trades at $79.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas LMB's P/E ratio is 24.47. In terms of profitability, ECG's ROE is +0.37%, compared to LMB's ROE of +0.22%. Regarding short-term risk, ECG is less volatile compared to LMB. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check LMB's competition here
ECG vs BWMN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, BWMN has a market cap of 479.8M. Regarding current trading prices, ECG is priced at $112.60, while BWMN trades at $28.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas BWMN's P/E ratio is 38.38. In terms of profitability, ECG's ROE is +0.37%, compared to BWMN's ROE of +0.05%. Regarding short-term risk, ECG is more volatile compared to BWMN. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check BWMN's competition here
ECG vs ORN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ORN has a market cap of 411.3M. Regarding current trading prices, ECG is priced at $112.60, while ORN trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ORN's P/E ratio is 171.00. In terms of profitability, ECG's ROE is +0.37%, compared to ORN's ROE of +0.02%. Regarding short-term risk, ECG is less volatile compared to ORN. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check ORN's competition here
ECG vs BBCP Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, BBCP has a market cap of 347.3M. Regarding current trading prices, ECG is priced at $112.60, while BBCP trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas BBCP's P/E ratio is 75.89. In terms of profitability, ECG's ROE is +0.37%, compared to BBCP's ROE of +0.02%. Regarding short-term risk, ECG is less volatile compared to BBCP. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check BBCP's competition here
ECG vs MTRX Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MTRX has a market cap of 288.9M. Regarding current trading prices, ECG is priced at $112.60, while MTRX trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MTRX's P/E ratio is -14.88. In terms of profitability, ECG's ROE is +0.37%, compared to MTRX's ROE of -0.14%. Regarding short-term risk, ECG is more volatile compared to MTRX. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check MTRX's competition here
ECG vs ESOA Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ESOA has a market cap of 231.1M. Regarding current trading prices, ECG is priced at $112.60, while ESOA trades at $12.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ESOA's P/E ratio is 96.62. In terms of profitability, ECG's ROE is +0.37%, compared to ESOA's ROE of +0.04%. Regarding short-term risk, ECG is more volatile compared to ESOA. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check ESOA's competition here
ECG vs MAGH Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MAGH has a market cap of 225.4M. Regarding current trading prices, ECG is priced at $112.60, while MAGH trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MAGH's P/E ratio is 225.33. In terms of profitability, ECG's ROE is +0.37%, compared to MAGH's ROE of +0.03%. Regarding short-term risk, ECG is more volatile compared to MAGH. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check MAGH's competition here
ECG vs AENZ Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, AENZ has a market cap of 177.9M. Regarding current trading prices, ECG is priced at $112.60, while AENZ trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas AENZ's P/E ratio is -6.06. In terms of profitability, ECG's ROE is +0.37%, compared to AENZ's ROE of -0.31%. Regarding short-term risk, ECG is less volatile compared to AENZ. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check AENZ's competition here
ECG vs CSLRW Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, CSLRW has a market cap of 133.1M. Regarding current trading prices, ECG is priced at $112.60, while CSLRW trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas CSLRW's P/E ratio is N/A. In terms of profitability, ECG's ROE is +0.37%, compared to CSLRW's ROE of +0.32%. Regarding short-term risk, ECG is less volatile compared to CSLRW. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check CSLRW's competition here
ECG vs JLHL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, JLHL has a market cap of 116.9M. Regarding current trading prices, ECG is priced at $112.60, while JLHL trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas JLHL's P/E ratio is 30.19. In terms of profitability, ECG's ROE is +0.37%, compared to JLHL's ROE of +0.53%. Regarding short-term risk, ECG is more volatile compared to JLHL. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check JLHL's competition here
ECG vs SHIM Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SHIM has a market cap of 115M. Regarding current trading prices, ECG is priced at $112.60, while SHIM trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SHIM's P/E ratio is -1.79. In terms of profitability, ECG's ROE is +0.37%, compared to SHIM's ROE of +0.51%. Regarding short-term risk, ECG is less volatile compared to SHIM. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check SHIM's competition here
ECG vs OEG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, OEG has a market cap of 107.7M. Regarding current trading prices, ECG is priced at $112.60, while OEG trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas OEG's P/E ratio is -0.54. In terms of profitability, ECG's ROE is +0.37%, compared to OEG's ROE of -0.88%. Regarding short-term risk, ECG is less volatile compared to OEG. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check OEG's competition here
ECG vs AGFY Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, AGFY has a market cap of 94.4M. Regarding current trading prices, ECG is priced at $112.60, while AGFY trades at $47.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas AGFY's P/E ratio is -1.49. In terms of profitability, ECG's ROE is +0.37%, compared to AGFY's ROE of -1.83%. Regarding short-term risk, ECG is less volatile compared to AGFY. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check AGFY's competition here
ECG vs SKBL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SKBL has a market cap of 90.5M. Regarding current trading prices, ECG is priced at $112.60, while SKBL trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SKBL's P/E ratio is 157.00. In terms of profitability, ECG's ROE is +0.37%, compared to SKBL's ROE of +0.12%. Regarding short-term risk, ECG is less volatile compared to SKBL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check SKBL's competition here
ECG vs BLNK Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, BLNK has a market cap of 65.6M. Regarding current trading prices, ECG is priced at $112.60, while BLNK trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas BLNK's P/E ratio is -0.52. In terms of profitability, ECG's ROE is +0.37%, compared to BLNK's ROE of -1.32%. Regarding short-term risk, ECG is less volatile compared to BLNK. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check BLNK's competition here
ECG vs VATE Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, VATE has a market cap of 57.8M. Regarding current trading prices, ECG is priced at $112.60, while VATE trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas VATE's P/E ratio is -0.75. In terms of profitability, ECG's ROE is +0.37%, compared to VATE's ROE of +0.33%. Regarding short-term risk, ECG is less volatile compared to VATE. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check VATE's competition here
ECG vs MGN Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MGN has a market cap of 48.9M. Regarding current trading prices, ECG is priced at $112.60, while MGN trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MGN's P/E ratio is 54.33. In terms of profitability, ECG's ROE is +0.37%, compared to MGN's ROE of +0.15%. Regarding short-term risk, ECG is less volatile compared to MGN. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check MGN's competition here
ECG vs SLND Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SLND has a market cap of 43M. Regarding current trading prices, ECG is priced at $112.60, while SLND trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SLND's P/E ratio is -0.45. In terms of profitability, ECG's ROE is +0.37%, compared to SLND's ROE of -0.69%. Regarding short-term risk, ECG is less volatile compared to SLND. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check SLND's competition here
ECG vs RITR Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, RITR has a market cap of 37.4M. Regarding current trading prices, ECG is priced at $112.60, while RITR trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas RITR's P/E ratio is 29.98. In terms of profitability, ECG's ROE is +0.37%, compared to RITR's ROE of +0.01%. Regarding short-term risk, ECG is less volatile compared to RITR. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check RITR's competition here
ECG vs DRTT Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, DRTT has a market cap of 34.9M. Regarding current trading prices, ECG is priced at $112.60, while DRTT trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas DRTT's P/E ratio is -1.45. In terms of profitability, ECG's ROE is +0.37%, compared to DRTT's ROE of -0.43%. Regarding short-term risk, ECG is less volatile compared to DRTT. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check DRTT's competition here
ECG vs ONEG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ONEG has a market cap of 21.8M. Regarding current trading prices, ECG is priced at $112.60, while ONEG trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ONEG's P/E ratio is -83.50. In terms of profitability, ECG's ROE is +0.37%, compared to ONEG's ROE of -0.05%. Regarding short-term risk, ECG is less volatile compared to ONEG. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check ONEG's competition here
ECG vs PGHL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, PGHL has a market cap of 21.4M. Regarding current trading prices, ECG is priced at $112.60, while PGHL trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas PGHL's P/E ratio is 27.00. In terms of profitability, ECG's ROE is +0.37%, compared to PGHL's ROE of +0.29%. Regarding short-term risk, ECG is less volatile compared to PGHL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check PGHL's competition here
ECG vs MSW Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MSW has a market cap of 14.9M. Regarding current trading prices, ECG is priced at $112.60, while MSW trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MSW's P/E ratio is -2.40. In terms of profitability, ECG's ROE is +0.37%, compared to MSW's ROE of -5.78%. Regarding short-term risk, ECG is more volatile compared to MSW. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check MSW's competition here
ECG vs WLMS Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, WLMS has a market cap of 9.7M. Regarding current trading prices, ECG is priced at $112.60, while WLMS trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas WLMS's P/E ratio is -0.76. In terms of profitability, ECG's ROE is +0.37%, compared to WLMS's ROE of -0.47%. Regarding short-term risk, ECG is less volatile compared to WLMS. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check WLMS's competition here
ECG vs FBGL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, FBGL has a market cap of 9.7M. Regarding current trading prices, ECG is priced at $112.60, while FBGL trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas FBGL's P/E ratio is -23.97. In terms of profitability, ECG's ROE is +0.37%, compared to FBGL's ROE of -0.17%. Regarding short-term risk, ECG is less volatile compared to FBGL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check FBGL's competition here
ECG vs MIMI Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, MIMI has a market cap of 8.3M. Regarding current trading prices, ECG is priced at $112.60, while MIMI trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas MIMI's P/E ratio is -4.74. In terms of profitability, ECG's ROE is +0.37%, compared to MIMI's ROE of -0.40%. Regarding short-term risk, ECG is less volatile compared to MIMI. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check MIMI's competition here
ECG vs ENG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ENG has a market cap of 5.6M. Regarding current trading prices, ECG is priced at $112.60, while ENG trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ENG's P/E ratio is -0.81. In terms of profitability, ECG's ROE is +0.37%, compared to ENG's ROE of -3.46%. Regarding short-term risk, ECG is more volatile compared to ENG. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check ENG's competition here
ECG vs OFAL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, OFAL has a market cap of 5.5M. Regarding current trading prices, ECG is priced at $112.60, while OFAL trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas OFAL's P/E ratio is -1.26. In terms of profitability, ECG's ROE is +0.37%, compared to OFAL's ROE of -0.12%. Regarding short-term risk, ECG is less volatile compared to OFAL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check OFAL's competition here
ECG vs SKK Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SKK has a market cap of 5M. Regarding current trading prices, ECG is priced at $112.60, while SKK trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SKK's P/E ratio is 4.43. In terms of profitability, ECG's ROE is +0.37%, compared to SKK's ROE of +0.09%. Regarding short-term risk, ECG is more volatile compared to SKK. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check SKK's competition here
ECG vs SUNE Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SUNE has a market cap of 4.1M. Regarding current trading prices, ECG is priced at $112.60, while SUNE trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SUNE's P/E ratio is N/A. In terms of profitability, ECG's ROE is +0.37%, compared to SUNE's ROE of -1.21%. Regarding short-term risk, ECG is less volatile compared to SUNE. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check SUNE's competition here
ECG vs WXM Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, WXM has a market cap of 3.1M. Regarding current trading prices, ECG is priced at $112.60, while WXM trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas WXM's P/E ratio is -0.94. In terms of profitability, ECG's ROE is +0.37%, compared to WXM's ROE of -0.72%. Regarding short-term risk, ECG is less volatile compared to WXM. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check WXM's competition here
ECG vs BNC Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, BNC has a market cap of 2.6M. Regarding current trading prices, ECG is priced at $112.60, while BNC trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas BNC's P/E ratio is -0.77. In terms of profitability, ECG's ROE is +0.37%, compared to BNC's ROE of +2.17%. Regarding short-term risk, ECG is less volatile compared to BNC. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check BNC's competition here
ECG vs OIG Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, OIG has a market cap of 1.8M. Regarding current trading prices, ECG is priced at $112.60, while OIG trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas OIG's P/E ratio is -0.01. In terms of profitability, ECG's ROE is +0.37%, compared to OIG's ROE of +12.50%. Regarding short-term risk, ECG is less volatile compared to OIG. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check OIG's competition here
ECG vs WLGS Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, WLGS has a market cap of 1.4M. Regarding current trading prices, ECG is priced at $112.60, while WLGS trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas WLGS's P/E ratio is -0.26. In terms of profitability, ECG's ROE is +0.37%, compared to WLGS's ROE of -0.54%. Regarding short-term risk, ECG is more volatile compared to WLGS. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check WLGS's competition here
ECG vs FGL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, FGL has a market cap of 885.6K. Regarding current trading prices, ECG is priced at $112.60, while FGL trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas FGL's P/E ratio is -0.67. In terms of profitability, ECG's ROE is +0.37%, compared to FGL's ROE of -0.32%. Regarding short-term risk, ECG is less volatile compared to FGL. This indicates potentially lower risk in terms of short-term price fluctuations for ECG.Check FGL's competition here
ECG vs SCCI Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, SCCI has a market cap of 0. Regarding current trading prices, ECG is priced at $112.60, while SCCI trades at N/A.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas SCCI's P/E ratio is N/A. In terms of profitability, ECG's ROE is +0.37%, compared to SCCI's ROE of +0.08%. Regarding short-term risk, Volatility data is not available for a full comparison. ECG has daily volatility of 4.74 and SCCI has daily volatility of N/A.Check SCCI's competition here
ECG vs ATCX Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, ATCX has a market cap of 0. Regarding current trading prices, ECG is priced at $112.60, while ATCX trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas ATCX's P/E ratio is -58.33. In terms of profitability, ECG's ROE is +0.37%, compared to ATCX's ROE of +0.07%. Regarding short-term risk, ECG is more volatile compared to ATCX. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check ATCX's competition here
ECG vs HIL Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, HIL has a market cap of 0. Regarding current trading prices, ECG is priced at $112.60, while HIL trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas HIL's P/E ratio is N/A. In terms of profitability, ECG's ROE is +0.37%, compared to HIL's ROE of -0.04%. Regarding short-term risk, ECG is more volatile compared to HIL. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check HIL's competition here
ECG vs IEA Comparison March 2026
ECG plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ECG stands at 5.7B. In comparison, IEA has a market cap of 0. Regarding current trading prices, ECG is priced at $112.60, while IEA trades at $13.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ECG currently has a P/E ratio of 28.52, whereas IEA's P/E ratio is -5.97. In terms of profitability, ECG's ROE is +0.37%, compared to IEA's ROE of +4.73%. Regarding short-term risk, ECG is more volatile compared to IEA. This indicates potentially higher risk in terms of short-term price fluctuations for ECG.Check IEA's competition here